glp-1/gip vs tirzepatide When it comes to the different types of GLP-1s, like vs. semaglutide, what's the difference? Our endocrine clinical pharmacist explains Tirzepatide vs Retatrutide: GLP-1 Research

Tirzepatide is the agonist of GLP-1 receptor and glucose-dependent insulinotropic polypeptide (GIP) receptor, which can reduce body weight and improve cardiac metabolism by subcutaneous injection once a week (Jastreboff et al 2022)

Still, obesity and metabolic disorders have increased dramatically for both groups over the last decade

Fatigue: Feeling tired or even exhausted is a common side effect

Introduction Antipsychotic-induced weight gain (AIWG) contributes significantly to the 2-3-fold higher rates of obesity seen amongst those living with a severe mental illness (SMI) ( where lifestyle interventions and/or switching psychotropic medication do not appear successful, adjunctive metformin may be considered